Medimmune
  • ABOUT MEDIMMUNE
    • Key Facts & Figures
    • Products
    • Facilities
    • At the Forefront
  • OUR CULTURE
    • History & Highlights
    • Visionaries at MedImmune
    • Executive Team
    • Corporate Responsibility
  • R & D
    • Pipeline
    • Drug Phase Chart
    • Biologics
    • Technologies & Approaches
    • Partnering
  • VENTURES
    • Investing in Our Future
    • Portfolio
  • PRESS ROOM
  • CAREERS
  • CONTACT
  • Home >
    • News & Media

News and Media

For press releases:

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

Receive E-mail alerts

Subscribe to RSS feeds

December 15, 2008
SDI and MedImmune Publish Ground-Breaking Study on Geographically Specific, Seasonal RSV Disease Outbreak Data
December 4, 2008
MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
November 28, 2008
MedImmune Receives FDA Complete Response Letter on Motavizumab
November 17, 2008
MedImmune Announces Winners of Third Annual Research Abstract Competition
November 13, 2008
MedImmune Announces Zook as President
November 3, 2008
MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
October 24, 2008
MedImmune to Present Nine Abstracts on RSV and Influenza at 48th Annual ICAAC/46th Annual IDSA Meeting
October 23, 2008
MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
October 16, 2008
MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
October 16, 2008
MedImmune Licenses Reverse Genetics Technology to Hungary's Omninvest for Use in Influenza Vaccine Development and Production
October 13, 2008
MedImmune Grants Five New Fellowships to Help Expand Premature Infant Follow-Up Care Research
October 11, 2008
MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
September 29, 2008
MedImmune Licenses Reverse Genetics Technology to Japan's BIKEN for Use in Influenza Vaccine Development and Production
September 11, 2008
MedImmune Further Expands Autoimmune Disease Research Program Through Collaboration with SBI Biotech
August 21, 2008
Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu
August 12, 2008
MedImmune Initiates First Phase 2 Trial in Lupus Patients With its Antibody Targeting Interferon-alpha
August 4, 2008
FluMist(R) Now Available for the 2008-2009 Flu Season
June 12, 2008
Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
June 6, 2008
MedImmune's Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awards Dinner
May 15, 2008
Depth of MedImmune's Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society
May 6, 2008
MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
May 5, 2008
Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors' Visits
May 5, 2008
Efficacy of FluMist(R) in Children Highlighted at Pediatric Academic Societies Meeting
May 5, 2008
Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
May 4, 2008
Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting
April 28, 2008
Fourteen Abstracts Featuring MedImmune's Influenza and RSV Therapeutic Areas to Be Presented at Pediatric Academic Societies Annual Meeting
April 15, 2008
MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
April 15, 2008
Preclinical Data Highlighting Potential of Retaspimycin in Treating Non-Small Cell Lung Cancer With Acquired Drug Resistance Presented by Infinity and MedImmune At AACR
April 10, 2008
MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research
March 27, 2008
Seneca Valley High School Student Receives Science Award From MedImmune
March 18, 2008
MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
February 27, 2008
MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations
February 19, 2008
Neonatologists and Pediatricians Highlight Progress and Barriers to Preemie Care
February 7, 2008
MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
February 4, 2008
MedImmune Submits Biologics License Application to FDA for Motavizumab
February 4, 2008
Infinity and MedImmune Announce Approval for Generic Name for Novel Hsp90 Inhibitor
January 7, 2008
MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
January 4, 2008
Infinity and MedImmune Initiate Phase 1b Trial of IPI-504 in Combination with Taxotere® in Patients with Advanced Solid Tumor Cancers
  • Terms and Conditions
  • |
  • Privacy Policy
  • |
  • Site Map
  • |
  • Contact Us
  • |
  • Glossary
Copyright © 2009 MedImmune, LLC. All rights reserved.